News
3hon MSN
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
World Health Organization (WHO) recommends injectable lenacapavir for Human Immunodeficiency Virus (HIV) prevention ...
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...
Thanks to a landmark deal announced on July 9 by the Global Fund, Uganda is expected to be among the first countries in sub-Saharan Africa to get access to Lenacapavir, a revolutionary new drug that ...
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...
One way to cope with cuts in HIV prevention funding is to continue to push to increase the number of people who self-test for HIV instead of getting tested at a clinic or hospital, experts at a series ...
A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...
The Minister’s address was particularly notable for the announcement of a planned rollout of lenacapavir, a biannual ...
The Global Fund has secured access to lenacapavir, a groundbreaking HIV prevention drug, for low and middle-income countries, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results